Tag: neuroleptics

Emerging Schizophrenia Drugs Target Negative Symptoms

Late-stage trials of new antipsychotic drugs are showing promise in the control of negative symptoms, according to an overview presented by Current Psychiatry and the...

Once-Weekly Oral Antipsychotic for Schizophrenia on the Horizon

A novel, ultra-long-acting oral formulation of the antipsychotic risperidone (Risperdal) only needs to be taken once weekly and appears to be safe and effective, results...

Anticholinergics a Key Contributor to Cognitive Impairment

Anticholinergic medication burden from antipsychotics, antidepressants, and other psychotropics has a cumulative effect of worsening cognitive function in patients with schizophrenia, new research indicates. “The...

Motor Abnormalities a Harbinger of Serious Mental Illness?

Motor problems in children may be a harbinger of serious mental illness, new research suggests. Investigators found that motor abnormalities were twice as common among...

Potential First-in-Class Schizophrenia Drug Cuts Negative Symptoms

The novel antipsychotic agent SEP-363856 (Sunovion Pharmaceuticals) has a significant and ongoing effect on negative symptoms in patients with schizophrenia, new research shows. Results of...

A Reflection of a Life-Threatening Condition

When a 47-year-old woman with well-controlled schizophrenia attended the Smell and Taste Research Clinic in Chicago, Illinois, Justin Virk, MD, had no idea he was...

The New Neuroscience of Stuttering

Gerald Maguire has stuttered since childhood, but you might not guess it from talking to him. For the past 25 years, Maguire — a psychiatrist...

No Need for Antipsychotics to Recover?

Two new studies highlight the importance of early intervention in first-episode psychosis (FEP). In the first study, Australian investigators conclude that for some FEP patients,...

LAIs vs Usual Care for First Hospitalization in Early Psychosis

Treatment with a long-acting injectable antipsychotic (LAI) in early-phase schizophrenia can significantly delay time to first hospitalization, new research suggests. The Prevention of Relapse in...

Cariprazine Trumps Risperidone for Negative Schizophrenia Symptoms

The antipsychotic cariprazine (Reagila) is not only more effective than risperidone in treating patients with schizophrenia and persistent negative symptoms (PNS), it is also safe...

New Guidance to Optimize Antipsychotic Treatment

A new consensus statement recommends monitoring antipsychotic blood levels, also known as therapeutic drug monitoring (TDM), to inform treatment decisions and optimize safety and efficacy....

Nearly a Dozen Approved Drugs Could Be Effective Against COVID-19: Study

(Reuters) – At least 10 different drug compounds ranging from cancer therapies to antipsychotics and antihistamines may be effective at preventing the new coronavirus from...

Anti-NMDA Receptor Encephalitis or Primary Psychiatric Disorder?

It remains difficult to distinguish anti-NMDA receptor encephalitis from a primary psychiatric disorder, but recent studies have identified clinical features and proposed screening criteria that...

Striking Uptick in Anxiety, Other Psych Meds

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. The psychological, physical, and financial aspects of the ongoing COVID-19 pandemic...